JP2010511022A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010511022A5 JP2010511022A5 JP2009538758A JP2009538758A JP2010511022A5 JP 2010511022 A5 JP2010511022 A5 JP 2010511022A5 JP 2009538758 A JP2009538758 A JP 2009538758A JP 2009538758 A JP2009538758 A JP 2009538758A JP 2010511022 A5 JP2010511022 A5 JP 2010511022A5
- Authority
- JP
- Japan
- Prior art keywords
- vaccine
- ccid
- tetravalent
- chimeri
- den
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0655255 | 2006-12-01 | ||
| FR0655255A FR2909286B1 (fr) | 2006-12-01 | 2006-12-01 | Methode d'immunisation contre les 4 serotypes de la dengue |
| PCT/FR2007/052431 WO2008065315A1 (fr) | 2006-12-01 | 2007-11-30 | Methode d'immunisation contre les 4 serotypes de la dengue |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2010511022A JP2010511022A (ja) | 2010-04-08 |
| JP2010511022A5 true JP2010511022A5 (enExample) | 2010-10-28 |
| JP5269803B2 JP5269803B2 (ja) | 2013-08-21 |
Family
ID=38198298
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009538758A Expired - Fee Related JP5269803B2 (ja) | 2006-12-01 | 2007-11-30 | デング熱の４種の血清型に対する免疫付与のプロトコル |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7718359B2 (enExample) |
| EP (1) | EP2099483B1 (enExample) |
| JP (1) | JP5269803B2 (enExample) |
| KR (1) | KR20090087890A (enExample) |
| CN (1) | CN101541344A (enExample) |
| AR (1) | AR064009A1 (enExample) |
| AU (1) | AU2007327367B2 (enExample) |
| BR (1) | BRPI0718927A2 (enExample) |
| CA (1) | CA2668570A1 (enExample) |
| FR (1) | FR2909286B1 (enExample) |
| IL (2) | IL198466A (enExample) |
| MX (1) | MX2009004223A (enExample) |
| MY (1) | MY180698A (enExample) |
| TW (1) | TWI400249B (enExample) |
| WO (1) | WO2008065315A1 (enExample) |
| ZA (1) | ZA200902540B (enExample) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2007021672A2 (en) * | 2005-08-10 | 2007-02-22 | Acambis Inc. | Vaccination against dengue virus infection |
| FR2903605A1 (fr) * | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
| CN105944095B (zh) | 2008-03-05 | 2021-04-02 | 赛诺菲巴斯德有限公司 | 一种使含佐剂的疫苗组合物稳定的方法 |
| EP2143440A1 (fr) * | 2008-07-09 | 2010-01-13 | Sanofi Pasteur | Agent stabilisant et composition vaccinale comprenant un ou plusieurs flavivirus vivants atténués |
| CN102449172A (zh) * | 2009-06-01 | 2012-05-09 | 伊维拉根公司 | 施用针对登革病毒的疫苗的组合物和方法 |
| AU2010286368B2 (en) * | 2009-08-31 | 2015-09-03 | Gen-Probe Incorporated | Dengue virus assay |
| EP2353609A1 (en) | 2010-02-04 | 2011-08-10 | Sanofi Pasteur | Immunization compositions and methods |
| WO2012088041A1 (en) | 2010-12-20 | 2012-06-28 | Genvec, Inc. | Adenoviral vector-based dengue fever vaccine |
| KR20150036592A (ko) | 2012-07-24 | 2015-04-07 | 사노피 파스퇴르 | 백신 조성물 |
| US20150265695A1 (en) | 2012-07-24 | 2015-09-24 | Sanofi Pasteur | Vaccine compositions for prevention against dengue virus infection |
| BR112015012515B1 (pt) | 2012-11-30 | 2023-04-11 | Sanofi Pasteur | Uso de antígenos, construções de ácido nucleico ou vetores virais capazes de expressar uma partícula do tipo vírus (vlp) da dengue e de uma vacina contra sarampo, uma vacina contra caxumba e uma vacina contra rubéola |
| EP3010536A4 (en) * | 2013-06-21 | 2016-11-30 | Merck Sharp & Dohme | DENGUE VIRUS VACCINE COMPOSITIONS AND METHODS FOR USE THEREOF |
| TWI852899B (zh) | 2014-09-02 | 2024-08-21 | 法商賽諾菲巴斯德公司 | 疫苗組合物 |
| ES2927797T3 (es) | 2014-09-26 | 2022-11-11 | Seqirus Uk Ltd | Vacunación de sujetos inmunocomprometidos |
| EP3316905A1 (en) | 2015-07-03 | 2018-05-09 | Sanofi Pasteur | Concomitant dengue and yellow fever vaccination |
| US10004795B2 (en) | 2015-09-08 | 2018-06-26 | Fundacao Butantan | Process for preparing an attenuated tetravalent dengue vaccine |
| JP7313345B2 (ja) | 2017-10-05 | 2023-07-24 | サノフィ・パスツール | デング熱に対するブースターワクチン接種のための組成物 |
| US11590221B2 (en) | 2018-09-05 | 2023-02-28 | Takeda Vaccines, Inc. | Dengue vaccine unit dose and administration thereof |
| WO2021034349A1 (en) | 2019-08-16 | 2021-02-25 | Takeda Vaccines, Inc. | Methods for preventing dengue and hepatitis a |
| US20240076631A2 (en) | 2020-02-27 | 2024-03-07 | Takeda Vaccines, Inc. | Method for removing host cell dna from virus preparation |
| KR20230147098A (ko) * | 2021-01-28 | 2023-10-20 | 백신벤트 게엠베하 | B 세포 매개 면역 반응을 조절하기 위한 방법 및 수단(method and means for modulating b-cell mediated immune responses) |
| WO2023147342A2 (en) | 2022-01-25 | 2023-08-03 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
| WO2023158989A1 (en) | 2022-02-15 | 2023-08-24 | Takeda Vaccines, Inc. | Dengue vaccine batch mixing process |
| EP4519847A1 (en) | 2022-05-04 | 2025-03-12 | Takeda Vaccines, Inc. | Computer-based determination of flavivirus infectivity |
| CN120225693A (zh) | 2022-11-18 | 2025-06-27 | 武田疫苗股份有限公司 | 测定制剂中具有包含至少一个减毒基因座的核苷酸序列的活减毒黄病毒的比例的方法 |
| EP4626574A1 (en) | 2022-11-29 | 2025-10-08 | Takeda Vaccines, Inc. | Large-scale flaviviral vaccine production and manufacture |
| WO2025072259A1 (en) | 2023-09-25 | 2025-04-03 | Takeda Vaccines, Inc. | Coadministration of tetravalent dengue vaccine with hpv vaccine |
| WO2025122855A1 (en) | 2023-12-08 | 2025-06-12 | Takeda Vaccines, Inc. | A method for determining the concentration of residual vero cell genomic dna in a sample containing virus obtained from production in vero cells |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999061916A1 (en) | 1998-05-29 | 1999-12-02 | Epimmune, Inc. | Identification of broadly reactive dr restricted epitopes |
| US6537557B1 (en) | 1999-03-26 | 2003-03-25 | The United States Of America As Represented By The Secretary Of The Army | Attenuated dengue-4 virus vaccine |
| AU779280B2 (en) * | 1999-03-26 | 2005-01-13 | Walter Reed Army Institute Of Research | Multivalent dengue virus vaccine |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| DK2278012T3 (en) * | 2000-02-16 | 2015-12-07 | Us Government | Immunogenic dengue 2 virus chimeras |
| DE60040652D1 (de) * | 2000-05-30 | 2008-12-11 | Univ Mahidol | Attenuierte Stammen von Denguevirus und ihre Verwendungen in Impfstoffzusammensetzungen |
| EP1159969A1 (fr) | 2000-05-30 | 2001-12-05 | Aventis Pasteur | Vaccine composition |
| AU2003239932A1 (en) * | 2002-05-31 | 2003-12-19 | Acambis, Inc. | Tetravalent dengue vaccines |
| ES2345200T3 (es) * | 2003-03-24 | 2010-09-17 | The Scripps Research Institute | Vacunas de adn contra el crecimiento tumoral y procedimientos de utilizacion de las mismas. |
| WO2006134433A1 (en) * | 2005-06-17 | 2006-12-21 | Sanofi Pasteur | Dengue serotype 1 attenuated strain |
| DE602006015807D1 (de) * | 2005-06-17 | 2010-09-09 | Ct S For Disease Control & Pre | Abgeschwächter dengue-serotyp-2-stamm |
| WO2007021672A2 (en) * | 2005-08-10 | 2007-02-22 | Acambis Inc. | Vaccination against dengue virus infection |
| US7968102B2 (en) * | 2006-01-13 | 2011-06-28 | Sanofi Pasteur S.A. | Dengue chimeric viruses |
| AR061197A1 (es) * | 2006-06-07 | 2008-08-13 | Sanofi Pasteur | Cepas del virus 3 del dengue vivas atenuadas |
| FR2903605A1 (fr) * | 2006-07-12 | 2008-01-18 | Sanofi Pasteur Sa | Methode d'immunisation contre les quatres serotypes de la dengue |
| FR2906724B1 (fr) * | 2006-10-04 | 2009-03-20 | Sanofi Pasteur Sa | Methode d'immunisation contre les 4 serotypes de la dengue. |
-
2006
- 2006-12-01 FR FR0655255A patent/FR2909286B1/fr not_active Expired - Fee Related
-
2007
- 2007-11-14 TW TW096143113A patent/TWI400249B/zh not_active IP Right Cessation
- 2007-11-21 US US11/944,311 patent/US7718359B2/en not_active Expired - Fee Related
- 2007-11-28 AR ARP070105280A patent/AR064009A1/es unknown
- 2007-11-30 KR KR1020097010676A patent/KR20090087890A/ko not_active Abandoned
- 2007-11-30 MX MX2009004223A patent/MX2009004223A/es active IP Right Grant
- 2007-11-30 JP JP2009538758A patent/JP5269803B2/ja not_active Expired - Fee Related
- 2007-11-30 CN CNA2007800439553A patent/CN101541344A/zh active Pending
- 2007-11-30 AU AU2007327367A patent/AU2007327367B2/en not_active Ceased
- 2007-11-30 BR BRPI0718927-3A2A patent/BRPI0718927A2/pt not_active IP Right Cessation
- 2007-11-30 MY MYPI20091957A patent/MY180698A/en unknown
- 2007-11-30 EP EP07866551.0A patent/EP2099483B1/fr not_active Not-in-force
- 2007-11-30 WO PCT/FR2007/052431 patent/WO2008065315A1/fr not_active Ceased
- 2007-11-30 ZA ZA200902540A patent/ZA200902540B/xx unknown
- 2007-11-30 CA CA002668570A patent/CA2668570A1/en not_active Abandoned
-
2009
- 2009-04-30 IL IL198466A patent/IL198466A/en not_active IP Right Cessation
-
2010
- 2010-03-05 US US12/718,931 patent/US20100239612A1/en not_active Abandoned
-
2013
- 2013-12-19 IL IL230052A patent/IL230052A0/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2010505801A5 (enExample) | ||
| MX2009004223A (es) | Protocolo de inmunizacion contra los 4 serotipos del dengue. | |
| JP2015524421A5 (enExample) | ||
| WO2008022196A3 (en) | Development of dengue virus vaccine components | |
| Plotkin | History of vaccination | |
| JP2010521961A5 (enExample) | ||
| WO2010012069A8 (en) | Multivalent vaccines based on papaya mosaic virus and uses thereof | |
| JP2007302683A5 (enExample) | ||
| JP2009539965A5 (enExample) | ||
| EP2601969A3 (en) | Norovirus vaccine formulations | |
| BRPI0908489A2 (pt) | uso de compostos químicos e método para desenhar compostos químicos que atenuam ou inibem a infecção pelo vírus da dengue | |
| CY1114298T1 (el) | Διαμορφωτικως περιορισμενα διφαινυλ παραγωγα για χρηση ως αναστολεις ιου ηπατιτιδας c | |
| JP2011051997A5 (enExample) | ||
| NZ597000A (en) | Compositions and methods for administration of vaccines against dengue virus | |
| WO2010025109A8 (en) | Vaccine against highly pathogenic porcine reproductive and respiratory syndrome (hp prrs) | |
| JP2010500398A5 (enExample) | ||
| CA2915027A1 (en) | Compositions and methods for administration of vaccines against dengue virus | |
| JP2008531742A5 (enExample) | ||
| JP2010532656A5 (enExample) | ||
| JP2016504315A5 (enExample) | ||
| JP2019511221A5 (enExample) | ||
| Wang et al. | Biomineralization state of viruses and their biological potential | |
| WO2006099360A3 (en) | Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus | |
| JP2020527540A5 (enExample) | ||
| CU20120057A7 (es) | Composición vacunal contra el virus del dengue, kit y plásmido |